Back
Vanguard Mortgage-Backed Secs Idx Fund ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
24
VMBS
Vanguard Mortgage-Backed Secs Idx Fund ETF
Last Price:
$47.14
Seasonality Move:
-0.65%
Sell
44
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$112.28
Seasonality Move:
-13.08%
Sell
24
Vanguard Mortgage-Backed Secs Idx Fund ETF (VMBS)
is a Sell
Is Vanguard Mortgage-Backed Secs Idx Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Mortgage-Backed Secs Idx Fund ETF [VMBS] share price is $47.03. The Score for VMBS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
VMBS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $112.35. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VMBS Stock Price Chart
What is Vanguard Mortgage-Backed Secs Idx Fund ETF's stock price today?
-
The Vanguard Mortgage-Backed Secs Idx Fund ETF share price today is $47.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VMBS is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $112.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
VMBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.46 | Buy |
| Relative Strength Index (14 RSI): | 47.75 | Sell |
| Chaikin Money Flow: | -527162 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.96 - 47.2) | Sell |
| Bollinger Bands (100): | (46.57 - 47.25) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 27.72 | Buy |
| Relative Strength Index (14 RSI): | 57.3 | Buy |
| Chaikin Money Flow: | -242725 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.69 - 112.27) | Buy |
| Bollinger Bands (100): | (96.46 - 108.94) | Buy |
VMBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.06 | Sell |
| 20-day SMA: | 47.1 | Sell |
| 50-day SMA: | 47.13 | Sell |
| 200-day SMA: | 46.39 | Buy |
| 8-day EMA: | 29.83 | Buy |
| 20-day EMA: | 15.52 | Buy |
| 50-day EMA: | 6.96 | Buy |
| 200-day EMA: | 1.85 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.44 | Sell |
| 20-day SMA: | 108.72 | Buy |
| 50-day SMA: | 106.88 | Buy |
| 200-day SMA: | 83.85 | Buy |
| 8-day EMA: | 80.33 | Buy |
| 20-day EMA: | 44.19 | Buy |
| 50-day EMA: | 20.34 | Buy |
| 200-day EMA: | 5.47 | Buy |
Vanguard Mortgage-Backed Secs Idx Fund ETF Earnings Growth & VMBS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.47 per share.
Vanguard Mortgage-Backed Secs Idx Fund ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||